top of page

Pain Management

Endonovo tPEMF technology is FDA approved for the treatment of post-operative pain and edema. Studies have demonstrated that the Enonovo tPEMF technology is at least as effective as NSAIDs in the treatment of pain and edema1.


In a 2008 study, patients treated with Endonovo tPEMF technology experienced a decrease in pain medication by nearly 3-fold in the treated patients compared with the control group.2

Chronic Pain: Financial Impact

 

Chronic pain poses an enormous economic burden on society both
in terms of medical care and lost productivity.

  • A National Institutes of Health report in 2011 estimated the total annual incremental cost of health care due to pain in the United States at $261-$300 billion.

  • The total cost to society, including indirect costs of pain due to lower economic productivity, was estimated at $560-$635 billion —greater than the cost of heart disease, cancer, or diabetes.

Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US); 2011.

Guy Working Out

Effects of Pulsed Electromagnetic Fields on Postoperative Pain: A Double-blind Randomized Pilot Study in Breast Augmentation Patients.

[See Attached Study]

Heden P, Pilla AA. 2008

Modulation of Carrageenan-induced Paw Edema and Hyperalgesia in the Rat with Pulsed Magnetic Field Therapy.  [See Attached Study]

Johnson MT, Ramanthan M,
Owegi R, Pilla AA, 2008 

Effects of Pulsed Electromagnetic Field Therapy on Post-Surgical Pain: A Randomized Placebo Controlled Double Blind Study in Breast Reconstruction Patients. [See Attached Study]

Gabriel, Maxell; 2009

Effects of Pulsed Electromagnetic Fields on Interleukin-1 and Postoperative Pain: A Double-Blind, Placebo-Controlled, Pilot Study in Breast Reduction Patients. [See Attached Study]

Rhode, 2010

Related Research

Related Pain Research
Endonovo Therapeutics logo

Contact Us:  info@sofpulse.com

Copyright 2018-2019 Endonovo Therapeutics, Inc.
All Rights Reserved | Sitemap | www.endonovo.com

  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon

The information included in this web site has been prepared for and is intended for viewing by residents of the United States of America. This web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us regarding the purchase or sale of SofPulse in other countries.

bottom of page